Pharmacological therapy for hypertensive children: an "additional bypass" of lifestyle interventions
- PMID: 20530291
- DOI: 10.1161/HYPERTENSIONAHA.110.155002
Pharmacological therapy for hypertensive children: an "additional bypass" of lifestyle interventions
Comment on
-
A double-blind, dose-response study of the efficacy and safety of olmesartan medoxomil in children and adolescents with hypertension.Hypertension. 2010 Jun;55(6):1323-30. doi: 10.1161/HYPERTENSIONAHA.109.147702. Epub 2010 Apr 12. Hypertension. 2010. PMID: 20385971 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
